Table 1.
Percentage and 95% confidence intervals (CI) of the proportion of samples positive to each molecular target in patients (cases) and healthy volunteers (controls).
| Molecular target | Cases (n = 49) | Controls (n = 32) | p |
|---|---|---|---|
| stx1 | 4.1 (1.1-13.7) | 3.1 (0.55-15.7) | 0.66 |
| stx2 | 0.0 (0.0-7.27) | 3.1 (0.55-15.7) | 0.40 |
| eae | 91.8 (80.8-96.8) | 93.8 (79.9-98.3) | 0.56 |
| ehxA | 40.8 (28.2-54.8) | 15.6 (6.86-31.8) | 0.014 |
| elt | 0.0 (0.0-7.27) | 0 (0.0-10.7) | – |
| est | 2.04 (0.36-10.7) | 0 (0.0-10.7) | 0.61 |
| invA | 81.6 (68.6-90.0) | 6.25 (1.73-20.1) | <0.001 |
| bfpA | 28.6 (17.8-42.4) | 31.3 (18.0-48.6) | 0.49 |
| aggR | 63.3 (49.3-75.3) | 50.0 (33.6-66.4) | 0.17 |
| O157+H7a | 53.1 (39.4-66.3) | 18.8 (8.89-35.3) | 0.002 |
| O104+H4a | 2.04 (0.36-10.7) | 18.8 (8.89-35.3) | 0.014 |
aIndicates simultaneous detection in a given sample of genes linked to the somatic and flagellar antigens (rfbO157, fliCH7, and wzxO104, fliCH4).
Significant p-values are highlighted in bold.